Shanghai Pharmaceutical Expands North; NDRC Price Cuts Impact M&A Targets

SHANGHAI - To accelerate its expansion and strengthen its presence in North China, Shanghai Pharmaceutical Holding Co. in January opened a new representative office in Beijing and established Beijing Shanghai Pharma Aixin Weiye Pharmaceutical Co., to be known as Weiye Pharma, while at the same time announcing the planned acquisition of China Health System